Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities

Europace

Volumn 9, Issue 6, 2007, Pages 391-397

  Frigo, Gianfranco ^a,b   Rampazzo, Alessandra ^a   Bauce, Barbara ^a   Pilichou, Kalliopi ^a   Beffagna, Giorgia ^a   Danieli, Gian Antonio ^a   Nava, Andrea ^a   Martini, Bortolo ^c  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b SAN MARTINO HOSPITAL   (Italy)

^c Boldrini Hospital   (Italy)

Author keywords

Brugada syndrome; Right ventricular abnormalities; SCN5A gene; Ventricular tachycardia

Indexed keywords

ARGININE; ATENOLOL; FLECAINIDE; GENOMIC DNA; GLUTAMINE; PROTEIN SCN5A; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANGIOCARDIOGRAPHY; ARTICLE; BRUGADA SYNDROME; CHROMOSOME 3; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; EXERCISE TEST; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; MALE; MICROSATELLITE MARKER; MISSENSE MUTATION; MONOMORPHIC VENTRICULAR TACHYCARDIA; MUTATIONAL ANALYSIS; PEDIGREE ANALYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ST SEGMENT ELEVATION;

ADULT; BIOLOGICAL MARKERS; BRUGADA SYNDROME; CORONARY ANGIOGRAPHY; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENETIC SCREENING; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MUSCLE PROTEINS; MUTATION; PEDIGREE; PHENOTYPE; SODIUM CHANNELS; TACHYCARDIA, VENTRICULAR;

EID: 34547861207     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum053     Document Type: Article

References (41)

1. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R et al. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 1989; 118:1203-9.
2. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20 1391-6.
3. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada Syndrome. Report of the Second Consensus Conference. Circulation 2005; 111:659-70.
4. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998;392:293-6.
5. Martini B, Corrado D, Nava A, Thiene G. Syndrome of right bundle branch block, ST segment elevation and sudden death. Evidence of an organic substrate. In: Nava A, Rossi L, Thiene G, eds. Arrhythmogenic right ventricular cardiomyopathy/displasia. Amsterdam: Elsevier; 1997. p. 438-53.
6. Martini B, Nava A. 1988-2003. Fifteen years after the first Italian description by Nava-Martini-Thiene and colleagues of a new sindrome (different from the Brugada syndrome?) in the Giornale Italiano di Cardiologia: Do we really know everything on this entity? Ital Heart J 2004;5:53-60.
7. Takagi M, Aihara N, Kuribayashi S, Taguchi A, Shimizu W, Kurita T et al. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. Eur Heart J 2001;22 1032-41.
8. Papavassiliu T, Wolpert C, Flüchter S, Schimpf R, Neff W, Haase KK et al. Magnetic resonance imaging findings in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2004; 15:1133-38.
9. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJG, Verkerk AO, de Groot JR et al. Right ventricular fibrosis and condution delay in a patient with clinical signs of Brugada syndrome. A combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005; 112:2769-77.
10. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napoletano C, Rivolta I et al. Cardiac Histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005;112:3680-87.
11. Wang DIN, Viswanathan PC, Balser JR, George AL, Benson DW. Clinical, genetic and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 2002;105 341-6.
12. Bezzina C, Weldkamp MW, van den Berg M, Postma AV, Rook MB, Viersma J-W et al. A single Na+ channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999;85:1206-13.
13. Splawski I, Timothy K, Tateyama M, Clancy CE, Malthotra A, Beggs AH et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002;297:1333-6.
14. Priori SG, Napolitano C, Schwartz PJ, Bloise R, Clotti R, Ronchetti E. The elusive link between LQT3 and Brugada syndrome. The rate of flecainide challenge. Circulation 2000;102:945-7.
15. Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baro I et al. Novel SCN5A mutation Leading either to isolated cardiac conduction defect or Brugada syndrome in a Large French family. Circulation 2001;104:3081-6.
16. McNair WP, Ku L, Taylor MRG, Fain PR, Dao D, Wolfel E et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004;110:2163-67.
17. Kim H, Cho Y, Park Y, Lee H, Kang H, Nah D-Y et al. Underlying cardiomyopathy in patients with ST-segment elevation in the right precordial leads. Circ J 2006;70:719-25.
18. Shimada M, Miyazaki T, Miyoshi S, Soejima K, Hori S, Mitamura H et al. Sustained monomorphic ventricular tachicardia in a patient with Brugada syndrome. Jpn Circ J 1996;60:364-70.
19. Pinar Bermudez E, Garcia-Alberola A, Martinez Sanchez J, Sanchez Munoz JJ, Valdes Chiavarri M. Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome. PACE 2000;23:407-9.
20. Sastry BSK, Narasimhan C, Soma Raju B. Brugada syndrome with monomorphic ventricular tachycardia in a one-year-old child. Indian Heart J 2001;53:203-5.
21. Boersma LVA, Jaarsma W, Jessurun ER, Van Hemel NH, Wever EF. Brugada syndrome: A case report of monomorphic ventricular tachycardia. PACE 2001;24:112-5.
22. Ogawa M, Kumagai K, Saku K. Spontaneous right ventricular outflow tract tachycardia in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:838-40.
23. Dinckal MH, Davutoglu V, Akdemir I, Soydinc S, Kirilmaz A, Aksoy M. Incessant monomorphic ventricular tachicardia during febbrile illness in a patient with Brugada syndrome: Fatal electrical storm. Eurapace 2003;5:257-61.
24. Mok N-S, Chan N-Y. Brugada syndrome presenting with sustained monomorphic ventricular tachycardia. Int J Cardiol 2004;97 307-09.
25. Probst V, Evain S, Gournay V, Marie A, Schott JJ, Boisseau P et al. Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child. J Cardiovasc Electrophysiol 2006;17:97-100.
26. Daliento L, Rizzoli G, Thiene G, Nava A, Rinuncini M, Chioin R et al. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 1990;66:741-5.
27. Wilde AAM, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P et al. Proposed diagnostic criteria for the Brugada syndrome. Consensus Report. Circulation 2002;106:2514-19.
28. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-11.
29. Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi V et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricutar cardiomyopathy. Am J Hum Genet 2002;71:1200-6.
30. Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004; 36:1162-4.
31. Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, Lorenzon A et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 2006;113 1171-9.
32. Kupersmith J, Krongrad E, Waldo A. Conduction intervals and conduction velocity in the human cardiac conduction system. Studies during openheart surgery. Circulation 1973;47:776-85.
33. Gellens ME, George AL Jr, Chen LQ, Chahine M, Horn R, Barchi RL et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci USA 1992;89:554-8.
34. Bezzina C, Rook M, Wilde A. Cardiac sodium channel and inherited arrhythmia syndromes. Cardiovasc Res 2001;49:257-71.
35. Chen LO, Santarelli V, Horn R, Kallen RG. A unique role for the S4 segment of domain 4 in the inactivation sodium channels. J Gen Physiol 1996;108:549-56.
36. Francisa J, Antzelevitch C. Brugada syndrome. Int J Cardiol 2005; 101:173-8.
37. Furuhashi M, Uno K, Tsuchihashi K, Nagahara D, Hyakukoku M, Ohtomo T et al. Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population. Heart 2001;86:161-6.
38. Veldkamp MW, Viswanathan PC, Bezzina C, Baartscheer A, Wilde AA, Balser JR. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ Res 2000;86:e91-7.
39. Olson TM, Michels W, Ballew JD, Reyna SP, Karst ML, Herron KJ et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005;293:447-54.
40. Lupoglazoff JM, Cheav T, Baroudi G, Berthet M, Denjoy I, Cauchemez B et al. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res 2001;89:e16-21.
41. Bezzina CR, Rook MB, Groenewegen WA, Herfst LJ, van der Wal AC, Lam J et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 2003; 92:159-68.